Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions

  1. Kari Alitalo1,2,12
  1. 1Wihuri Research Institute,
  2. 2Translational Cancer Biology Program, University of Helsinki, Helsinki 00014, Finland;
  3. 3Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg, Heidelberg 69120, Germany;
  4. 4Department of Vascular Biology and Tumor Angiogenesis, Heidelberg University, Mannheim 68167, Germany;
  5. 5Department of Oncology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Epalinges CH-1066, Switzerland;
  6. 6FIRC Institute of Molecular Oncology, Milan 20139, Italy;
  7. 7Department of Biotechnological and Biomolecular Sciences, University of Milan, Milan 20129, Italy;
  8. 8Biomedicum Imaging Unit, Biomedicum Helsinki, University of Helsinki, Helsinki 00014, Finland;
  9. 9MedImmune, Gaithersburg, Maryland 20878, USA;
  10. 10Swiss Institute for Cancer Research, École Polytechnique Fédérale de Lausanne, Lausanne CH-1066, Switzerland

    Abstract

    Primitive lymphatic vessels are remodeled into functionally specialized initial and collecting lymphatics during development. Lymphatic endothelial cell (LEC) junctions in initial lymphatics transform from a zipper-like to a button-like pattern during collecting vessel development, but what regulates this process is largely unknown. Angiopoietin 2 (Ang2) deficiency leads to abnormal lymphatic vessels. Here we found that an ANG2-blocking antibody inhibited embryonic lymphangiogenesis, whereas endothelium-specific ANG2 overexpression induced lymphatic hyperplasia. ANG2 inhibition blocked VE-cadherin phosphorylation at tyrosine residue 685 and the concomitant formation of button-like junctions in initial lymphatics. The defective junctions were associated with impaired lymph uptake. In collecting lymphatics, adherens junctions were disrupted, and the vessels leaked upon ANG2 blockade or gene deletion. ANG2 inhibition also suppressed the onset of lymphatic valve formation and subsequent valve maturation. These data identify ANG2 as the first essential regulator of the functionally important interendothelial cell–cell junctions that form during lymphatic development.

    Keywords

    Footnotes

    • Received January 7, 2014.
    • Accepted June 9, 2014.

    This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

    | Table of Contents

    Life Science Alliance